Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons
- 358 Downloads
Continuous glucose monitoring associated with intensive insulin regimens represents a useful tool to lower HbA1c in selected adults with type 1 diabetes. Recent randomized controlled trials demonstrated greater glycemic benefits in type 1 diabetic patients treated with multiple daily injections of insulin and continuous glucose monitoring over usual care. These positive outcomes, however, are counter-balanced by several limitations that restrict the use of continuous glucose monitoring in the real life, including the apparent lack of benefits in children and pregnant diabetic women, the high cost, the stringent patients’ selection, and the presence of a multi-disciplinary team with specific expertise. Pros and Cons of using continuous glucose monitoring in type 1 diabetic patients with multiple daily injections of insulin are here discussed.
KeywordsType 1 diabetes CGM Multiple daily injections Continuous subcutaneous insulin infusion
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
This article does not contain any studies with human participants performed by any of the authors.
- 1.American Diabetes Association.: 6. Glycemic Targets Diabetes Care. 40(Suppl.1), S48–S56 (2017)Google Scholar
- 4.A.L. Peters, A.J. Ahmann, T. Battelino, A. Evert, I.B. Hirsch, M.H. Murad, W.E. Winter, H. Wolpert, Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 3922–3937 (2016)CrossRefPubMedGoogle Scholar
- 5.W.V. Tamborlane, R.W. Beck, B.W. Bode, B. Buckingham, H.P. Chase, R. Clemons, R. Fiallo-Scharer, L.A. Fox, L.K. Gilliam, I.B. Hirsch, E.S. Huang, C. Kollman, A.J. Kowalski, L. Laffel, J.M. Lawrence, J. Lee, N. Mauras, M. O’Grady, K.J. Ruedy, M. Tansey, E. Tsalikian, S. Weinzime, D.M. Wilson, H. Wolpert, T. Wysocki, D. Xing; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Continuous glucose monitoring and intensive treatment of type 1 diabetes. N. Engl. J. Med. 359, 1464–1476 (2008)CrossRefPubMedGoogle Scholar
- 6.T. Battelino, I. Conget, B. Olsen, I. Schütz-Fuhrmann, E. Hommel, R. Hoogma, U. Schierloh, N. Sulli, J. Bolinder; SWITCH Study Group, The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55, 3155–3162 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
- 7.R.M. Bergenstal, W.V. Tamborlane, A. Ahmann, J.B. Buse, G. Dailey, S.N. Davis, C. Joyce, T. Peoples, B.A. Perkins, J.B. Welsh, S.M. Willi, M.A. Wood; STAR 3 Study Group, Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N. Engl. J. Med. 363, 311–320 (2010)CrossRefPubMedGoogle Scholar
- 8.M.I. Maiorino, G. Bellastella, M. Petrizzo, M.R. Improta, C. Brancario, F. Castaldo, L. Olita, D. Giugliano, K. Esposito, Treatment satisfaction and glycemic control in young type 1 diabetic patients in transition from pediatric health care: CSII versus MDI. Endocrine 46, 256–262 (2014)CrossRefPubMedGoogle Scholar
- 9.M.I. Maiorino, O. Casciano, E. Della Volpe, G. Bellastella, D. Giugliano, K. Esposito, Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study. Endocrine 52, 244–252 (2016)CrossRefPubMedGoogle Scholar
- 11.R.W. Beck, T. Riddlesworth, K. Ruedy, A. Ahmann, R. Bergenstal, S. Haller, C. Kollman, D. Kruger, J.B. McGill, W. Polonsky, E. Toschi, H. Wolpert, D. Price; DIAMOND Study Group, Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317, 371–378 (2017)CrossRefPubMedGoogle Scholar
- 12.M. Lind, W. Polonsky, I.B. Hirsch, T. Heise, J. Bolinder, S. Dahlqvist, E. Schwarz, A.F. Ólafsdóttir, A. Frid, H. Wedel, E. Ahlén, T. Nyström, J. Hellman, Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317, 379–387 (2017)CrossRefPubMedGoogle Scholar
- 13.C.A. van Beers, J.H. DeVries, S.J. Kleijer, M.M. Smits, P.H. Geelhoed-Duijvestijn, M.H. Kramer, M. Diamant, F.J. Snoek, E.H. Serné, Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 4, 893–902 (2016)CrossRefPubMedGoogle Scholar
- 14.K.M. Miller, N.C. Foster, R.W. Beck, R.M. Bergenstal, S.N. DuBose, L.A. DiMeglio, D.M. Maahs, W.V. Tamborlane; T1D Exchange Clinic Network, Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care 38, 971–978 (2015)CrossRefPubMedGoogle Scholar
- 15.N. Mauras, R. Beck, D. Xing, B. Buckingham, M. Tansey, N.H. White, S.A. Weinzimer, W. Tamborlane, C. Kollman; Diabetes Research in Children Network (DirecNet) Study Group, A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to\10 years. Diabetes Care 35, 204–210 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
- 16.M. Tansey, S. Weinzimer, R. Beck, K. Ruedy, P. Cheng, W. Tamborlane, C. Kollman, N. Mauras, L. Fox, J. Coffey, N.H. White; Diabetes Research in Children Network (DirecNet) Study Group, Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to<10 years. Diabetes Care 36, e63 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
- 19.U.S. Food and Drug Administration. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm534056.htm, Accessed 16 Mar 2017